GAZYVA

• tagApproval56 co-mentions · 14 sources
• drugobinutuzumab56 co-mentions · 14 sources

Trials studying GAZYVA

• phase2An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphomaactive not recruitingn=211
• phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participantsrecruitingn=40
• phase2A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemianot yet recruitingn=40
• phase1ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignanciescompletedn=16
• phase1A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphomarecruitingn=121
• phase3A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphomarecruitingn=780
• phase2Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndromeactive not recruitingn=249
• phase2Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphomanot yet recruitingn=40